| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oncology Institute, Inc. | Director | Common stock | 127K | $269K | $2.11 | Dec 26, 2023 | Direct |
| Dianthus Therapeutics, Inc. /DE/ | Director | Stock Option (Right to Buy) | 11K | May 23, 2024 | Direct | ||
| SOC Telemed, Inc. | Former Director | Class A Common Stock | 0 | $3.00 | Apr 6, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. /DE/ | May 23, 2024 | 1 | $0 | 4 | May 28, 2024 | Director |
| TOI | Oncology Institute, Inc. | Dec 26, 2023 | 1 | $0 | 4 | Dec 28, 2023 | Director |
| MGTA | Dianthus Therapeutics, Inc. /DE/ | Sep 11, 2023 | 1 | $0 | 4 | Sep 13, 2023 | Director |
| TOI | Oncology Institute, Inc. | Mar 17, 2023 | 1 | $0 | 4 | Mar 21, 2023 | Director |
| TOI | Oncology Institute, Inc. | Nov 17, 2022 | 1 | $0 | 4 | Nov 21, 2022 | Director |
| MGTA | Magenta Therapeutics, Inc. | Jun 28, 2022 | 1 | $0 | 4 | Jun 30, 2022 | Director |
| TLMD | SOC Telemed, Inc. | Apr 6, 2022 | 1 | -$175K | 4 | Apr 7, 2022 | Former Director |
| TOI | Oncology Institute, Inc. | Mar 21, 2022 | 2 | $0 | 4 | Mar 23, 2022 | Director |
| TOI | Oncology Institute, Inc. | Nov 12, 2021 | 0 | $0 | 3 | Nov 16, 2021 | Director |
| TLMD | SOC Telemed, Inc. | Jun 3, 2021 | 1 | $0 | 4 | Jun 7, 2021 | Director |
| MGTA | Magenta Therapeutics, Inc. | Jun 1, 2021 | 1 | $0 | 4 | Jun 3, 2021 | Director |